Elanco is a global innovation-driven company that develops and markets products to improve animal health and food animal production in more than 75 countries. Elanco employs more than 2,400 people worldwide, with offices in more than 40 countries, and is a division of Eli Lilly and Company, a leading global pharmaceutical corporation. Additional information about Elanco is available at www.elanco.com.
(GlobeNewswire) - Today, the recently-formed Elanco Foundation pledged more than $700,000 to help fight rising food insecurity challenges due to the novel coronavirus outbreak. The funds will support organizati...
(GLOBE NEWSWIRE) - Elanco Animal Health Inc. (NYSE: ELAN) today announced that its shared value East Africa Growth Accelerator (EAGA) initiative has delivered a Social Return on Investment (SROI) of almost 250% for dairy and poultry smallholder farmers, their families and other stake...
/PRNewswire/ - As global food insecurity reaches all-time highs, Elanco seeks to be an example of how one company can impact this growing crisis. Today, the company announced its commitment to end hunger for 100,000 families globally through a partnership with Heifer Interna...